Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

White wax and its policosanol boost hair growth better than finasteride.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose can help treat hair loss by reducing certain hormones and promoting hair growth.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

Scientists found key proteins and genes that affect skin and hair health, and identified potential new treatments for hair loss, skin disorders, and wound healing.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Potassium channels are important drug targets for treating conditions like hypertension, hair loss, and diabetes.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Male pattern baldness is common, affects quality of life, and new treatments like Propecia show promise.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Terbinafine is the most effective treatment for tinea capitis, a scalp infection often confused with other conditions.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

NH-Tween-80 is a promising stable gel for treating acne.

Certain genes are linked to the risk of developing Alopecia Areata.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.